ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Phoenix, AZ, USA:

Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer (LAPIS)

with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...

Active, not recruiting
Pancreatic Cancer Non-resectable
Drug: Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
Drug: Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX

Phase 3

FibroGen
FibroGen

Phoenix, Arizona, United States and 89 other locations

Bluestar Genomics has developed a non-invasive test that aids in detection of occult pancreatic cancer in patients with new onset t ...

Enrolling
Pancreatic Cancer
Other: MRI/Imaging
ClearNote Health

Scottsdale, Arizona, United States and 4 other locations

Phase 1 Safety and Tolerability Study in Subjects with Pancreatic Cancer or Other CA19-9 Positive Malignancies....

Enrolling
Pancreatic Cancer
Drug: gemcitabine + nab-paclitaxel
Drug: MVT-5873

Phase 1

BioNTech
BioNTech

Scottsdale, Arizona, United States and 4 other locations

A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...

Active, not recruiting
Pancreatic Cancer
Drug: Ramucirumab
Drug: mFOLFIRINOX

Phase 2

Walid Shaib, MD

Scottsdale, Arizona, United States and 7 other locations

drugs, Vemurafenib and Sorafenib, in individuals with KRAS mutated pancreatic cancer who have progressed on standard chemotherapy....

Enrolling
Pancreas Cancer
Drug: Sorafenib
Drug: Vemurafenib

Phase 2

HonorHealth Research Institute

Scottsdale, Arizona, United States

doses of L-DOS47 in combination with doxorubicin, as well as preliminary anti-tumor activity in patients with previously treated advanced pancreatic...

Enrolling
Pancreas Cancer
Biological: L-DOS47
Drug: Doxorubicin

Phase 1, Phase 2

Helix BioPharma

Scottsdale, Arizona, United States and 2 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

Goodyear, Arizona, United States and 22 other locations

This is a Phase 1b/2, open-label, multi-center, competitive enrollment and dose-escalation study of HCW9218 in patients with advanced/metastatic pancreatic...

Active, not recruiting
Advanced Pancreatic Carcinoma
Drug: HCW9218

Phase 1, Phase 2

HCW Biologics

Scottsdale, Arizona, United States and 4 other locations

compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Nab-paclitaxel
Drug: Gemcitabine

Phase 2

Agenus
Agenus

Scottsdale, Arizona, United States and 35 other locations

This proposed Phase I clinical trial of SON-DP is an FIH, open-label, Phase Ia/Ib dose escalation and expansion study to evaluate the safety, tolerab...

Enrolling
Breast Cancer
Ovarian Cancer
Drug: SON-DP

Phase 1

Qurgen

Gilbert, Arizona, United States and 4 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems